In this webinar, you'll learn to:
1) Define your marketing goals
2)Translate revenue goals into marketing KPIs
3) Set realistic budgets
4) Report on marketing performance relative to goals/budget
Register here for free: https://t.co/HXzuGSlayS
Free webinar tomorrow to help #Biotechnology companies decide when to invest in marketing and how to make the most of their budgets.
Tune in and say hi if you're free!
https://t.co/HXzuGSlayS
In order for #AI to make a big impact in the #Biopharmaceutical industry, there needs to be a paradigm shift. Right now, even large companies focus on only a limited number of targets. AI solves big data problems. We're limiting the data & thinking too small.
#SynBioBeta2024
If you look at the AI tools in other industries (take video games), biotech is way behind.
Interesting perspective from Kooshiar Azimian of @310ai#SynBioBeta2024
‘Because my genome was the first to be sequenced, many papers have been published about the diseases I’m supposed to die from, including several childhood diseases.’ - Craig Venter talking to Linda Avey at #synbiobeta2024
"50% of essential meds could be biomanufactured" predicts @antheiabio
I'm wondering, what would regulations/costs look like given the lack of savings realized on biosimilars/follow-on biologics to date?
Maybe biomanufactured small molecules would be different? ##synbiobeta2024
There’s new technology we need to develop to generate data sets for training AI - says Sean Mclain of @abscibio
Is it possible that all of the HTP screening platforms that haven't seen market success are now a hammer with a nail? What's the market for data?
#SynBioBeta2024
“A good platform creates great products. If you can’t create products, you don’t have a good platform”
Preach Omri Amirav-Drory! So many startups come to our door with no idea what they're actually selling.
@sambasci can help you ID your killer apps #SynBioBeta2024
“I remember being in grad school and people talking about slides that were TOO good,” said @thisischristina at #synbiobeta2024. Bad communication is the norm in the sciences, it's almost lauded. We can do better. Scientists are humans too, let's make it easy for them.
In a discussion about using AI to find small molecule drugs for "undruggable" targets, panelists imagine a future tool that's like Clippy meets PyMol
"It looks like you're designing a trispecific antibody, would you like help?"
#synbiobeta2024#machinelearning
Did the pandemic prime the investment community for RNA-based therapeutics?
@alltrna raised a $109B Series B round in 2023 (an abysmal year for biotech investment)...so maybe
Interesting panel discussion on new classes of therapeutics at #synbiobeta2024
Hundreds of materials can be made sustainably with biomanufacturing, but to make it practical, innovation is needed at every stage of the precision fermentation value chain, not just strain engineering.
Great talk by @BCG and @SynonymBio #synbiobeta2024
"Plants represent the ultimate biofactory for harvesting the power of nature with the basic ingredients of water, CO2, and sunlight"
Great insight from Alan Berry, CSO of @EloLifeSystems at #SynBioBeta2024
Engineered yeast cells
Not just for fermentation
They capture rare cells
That's a haiku.
About @samplinghuman's new single cell sequencing technology.
Check it out : https://t.co/CdkVZmaR4p
#Genetics#Biotechnology#biotech#synbio
🤔 Fluorescence + plants + satellite= healthy crops 🌱
@FoodBeerScience@SynBioBeta@Inner_Plant
Smart Plants are Coming to a Field Near You This Year - SynBioBeta https://t.co/IUc7ZdZ8Ci